$-0.13 EPS Expected for MediWound Ltd. (MDWD)

Analysts expect MediWound Ltd. (NASDAQ:MDWD) to report $-0.13 EPS on May, 9.They anticipate $0.04 EPS change or 23.53 % from last quarter’s $-0.17 EPS. After having $-0.06 EPS previously, MediWound Ltd.’s analysts see 116.67 % EPS growth. The stock decreased 1.47% or $0.07 during the last trading session, reaching $4.7. About 65,195 shares traded. MediWound Ltd. (NASDAQ:MDWD) has risen 13.85% since May 8, 2018 and is uptrending. It has outperformed by 9.48% the S&P500.

MediWound Ltd. (NASDAQ:MDWD) Ratings Coverage

Among 3 analysts covering Mediwound (NASDAQ:MDWD), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Mediwound had 5 analyst reports since March 12, 2019 according to SRatingsIntel. The stock of MediWound Ltd. (NASDAQ:MDWD) has “Buy” rating given on Monday, March 25 by Oppenheimer. Wells Fargo maintained the shares of MDWD in report on Tuesday, March 12 with “Buy” rating. The rating was maintained by Oppenheimer on Tuesday, March 12 with “Buy”. The company was maintained on Tuesday, March 12 by SunTrust.

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products in Israel. The company has market cap of $127.74 million. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. It currently has negative earnings. The firm also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds.

More notable recent MediWound Ltd. (NASDAQ:MDWD) news were published by: Seekingalpha.com which released: “IPO Could Fix MediWound Up For U.S. Market – Seeking Alpha” on March 19, 2014, also Nasdaq.com with their article: “Pre-Market Earnings Report for March 25, 2019 : WGO, ICLK, YRD, MDWD – Nasdaq” published on March 22, 2019, Seekingalpha.com published: “MediWound: Doubling Sales Even Before Likely FDA Approval – Seeking Alpha” on November 21, 2017. More interesting news about MediWound Ltd. (NASDAQ:MDWD) were released by: Nasdaq.com and their article: “Health Care Sector Update for 03/25/2019: ABMD,SRPT,NK,MDWD – Nasdaq” published on March 25, 2019 as well as Finance.Yahoo.com‘s news article titled: “Earnings Preview: MediWound (MDWD) Q4 Earnings Expected to Decline – Yahoo Finance” with publication date: March 11, 2019.

MediWound Ltd. (NASDAQ:MDWD) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.